Literature DB >> 3334241

Interaction between L-aspartic acid and L-asparaginase from Escherichia coli: binding and inhibition studies.

H N Jayaram1, D A Cooney, C Y Huang.   

Abstract

Experiments using equilibrium dialysis and fluorescence quenching provided direct evidence that approximately four moles of L-aspartic acid were bound per mole of tetrameric L-asparaginase from Escherichia coli, with a dissociation constant on the order of 60-160 microM. In addition, a set of weaker binding sites with a dissociation constant in the millimolar range were detected. Kinetic studies also revealed that L-aspartic acid inhibited L-asparaginase competitively, with an inhibition constant of 80 microM at micromolar concentrations of L-asparagine; at millimolar concentrations of the amide, an increase in maximal velocity but a decrease in affinity for L-asparagine were observed. L-Aspartic acid at millimolar levels again displayed competitive inhibition. These and other observations suggest that L-aspartic acid binds not only to the active site but also a second site with lower intrinsic affinity for it. The observed "substrate activation" is most likely attributable to the binding of a second molecule of L-asparagine rather than negative cooperativity among the tight sites of the subunits of this tetrameric enzyme. Further support for L-aspartic acid binding to the active site comes from experiments in which the enzyme, when exposed to various group-specific reagents suffered parallel loss of catalytic activity and in its ability to bind L-aspartic acid. Different commercial preparations of Escherichia coli L-asparaginase were found to contain approximately 2-4 moles of L-aspartic acid; these were incompletely removed by dialysis, but could be removed by transamination or decarboxylation. Efficiency of dialysis increased with increasing pH. Taken together, this set of results is consistent with the existence of a covalent beta-aspartyl enzyme intermediate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3334241     DOI: 10.3109/14756368609020113

Source DB:  PubMed          Journal:  J Enzyme Inhib        ISSN: 1026-5457


  3 in total

1.  Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy.

Authors:  A L Swain; M Jaskólski; D Housset; J K Rao; A Wlodawer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

2.  Immobilization and Characterization of L-Asparaginase over Carbon Xerogels.

Authors:  Rita A M Barros; Raquel O Cristóvão; Sónia A C Carabineiro; Márcia C Neves; Mara G Freire; Joaquim L Faria; Valéria C Santos-Ebinuma; Ana P M Tavares; Cláudia G Silva
Journal:  BioTech (Basel)       Date:  2022-04-14

3.  L-Asparaginase of Leishmania donovani: Metabolic target and its role in Amphotericin B resistance.

Authors:  Jasdeep Singh; Mohd Imran Khan; Shiv Pratap Singh Yadav; Ankit Srivastava; Kislay K Sinha; Pradeep Das; Bishwajit Kundu
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-09-28       Impact factor: 4.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.